Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/16/2013EP2648723A1 Bicyclic pyrazole compounds as allosteric modulators of mglur5 receptors
10/16/2013EP2648722A1 Compositions for treating dermatitis and ichthyosis, and methods for treating dermatitis and ichthyosis
10/16/2013EP2648721A1 Combinations of aromatase inhibitors and antioxidants
10/16/2013EP2648720A2 New pharmaceutical compositions
10/16/2013EP2648719A1 Treatment of her2-positive cancer with paclitaxel and trastuzumab-mcc-dm1
10/16/2013EP2648718A2 Implantable devices coated with insulin-mimetic agent composites and methods thereof
10/16/2013EP2648717A1 Composition for topical use for treating skin disorders
10/16/2013EP2648716A2 Subcutaneously infusible levodopa prodrug compositions and methods of infusion
10/16/2013EP2648715A2 Carnosine-hyaluronic acid mixtures and their use
10/16/2013EP2648714A2 Lysophosphatidic acid receptor antagonists and uses thereof
10/16/2013EP2648713A1 Dosages of arylsulfonamide derivatives
10/16/2013EP2648712A1 Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders
10/16/2013EP2648711A2 Compositions and methods for treating ophthalmic conditions
10/16/2013EP2648710A1 Pyridonyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
10/16/2013EP2648709A1 Disulfiram formulation and uses thereof
10/16/2013EP2648708A2 Combination for breast cancer therapy with hsp90 inhibitory compounds
10/16/2013EP2648707A1 Hydroxylated tricyclic compounds
10/16/2013EP2648706A2 Compositions and methods relating to proliferative diseases
10/16/2013EP2648705A1 Oral care compositions comprising a quinone and a further antimicrobial agent
10/16/2013EP2648704A1 Anti-microbial composition
10/16/2013EP2648703A1 Pharmaceutical composition comprising trans-cinnamaldehyde and its use in the treatment of infections
10/16/2013EP2648701A1 Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
10/16/2013EP2648700A1 Pharmaceutical composition comprising dutasteride
10/16/2013EP2648698A1 Liposomal formulation of dalcetrapib
10/16/2013EP2648696A1 New form of administration of enkephalinase inhibitor
10/16/2013EP2648681A1 An oral care composition
10/16/2013EP2648651A1 Methods and apparatuses useful for regulating bone remodeling or tooth movement using light therapy, a functional appliance, and/or vitamin d
10/16/2013EP2648549A1 Compositions and methods for nutrient delivery
10/16/2013EP2648520A1 Dexmedetomidine premix formulation
10/16/2013EP2648519A2 Novel polymorph of nilotinib hydrochloride
10/16/2013EP2648517A1 Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
10/16/2013EP2648516A1 Substituted pyridinone-pyridinyl compounds
10/16/2013EP2648513A1 Methods and compositions useful for promoting sleep in animals
10/16/2013EP2648511A1 Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
10/16/2013EP2648509A2 Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof
10/16/2013CN103354812A Imidazo [1, 2-A] pyridine sulfonamides as TRPM8 modulators
10/16/2013CN103354808A Anti-viral compounds
10/16/2013CN103354757A Treatment for lipodystrophy
10/16/2013CN103354749A Rapamycin formulation using recombinant high-density lipoprotein including apolipoprotein A-I and a mutant thereof
10/16/2013CN103354744A Combination treatment for dermatological conditions
10/16/2013CN103354743A Combination treatment for rosacea
10/16/2013CN103354742A Novel oxime azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10/16/2013CN103354719A Water soluble nutritional compositions comprising cereal beta-glucan and resistant starch
10/16/2013CN103351420A Compound obtained from Momordica charantia L. through separation and preparation method and application thereof
10/16/2013CN103351415A Method for preparing salidrosides with a series of purities from glossy privet fruit
10/16/2013CN103351407A Novel crystal form of cocarboxylase tetrahydrate
10/16/2013CN103351395A Esterified podophyllum derivative with antineoplastic activity and preparation method and application thereof
10/16/2013CN103351394A Acidamide substitution podophyllum derivative with antineoplastic activity and preparation method and application thereof
10/16/2013CN103351391A Compound serving as dipeptidyl enzyme inhibitor, composite of compound, and applications of compound and composite
10/16/2013CN103351390A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
10/16/2013CN103351389A Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
10/16/2013CN103351388A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
10/16/2013CN103351387A Preparation method of pyrroloquinolinequinone lithium salt crystal and applications thereof
10/16/2013CN103351383A 5-fluorouracil nitroxyl-free-radical anti-tumor drug
10/16/2013CN103351377A Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase n inhibitors
10/16/2013CN103351367A Hydrochloride salt of 5-r3-f3-tivdroxyphenoxy)azetidip-1-vp-5-methyl-2.2- diphenylhexanamide
10/16/2013CN103351336A Naphthalenecarboxamide derivative as inhibitors of protein kinase and histone deacetylase and preparation method thereof
10/16/2013CN103351308A Positively charged water-soluble 4-acetamidophenol having rapid skin penetration speed, and related compound prodrug thereof
10/16/2013CN103351285A Diethylstilbestrol compound and application thereof in preparation of drug for treating osteoporosis and hyperlipemia
10/16/2013CN103349776A Edaravone injection solution and preparation method thereof
10/16/2013CN103349763A Drug for treating acquired immune deficiency syndrome
10/16/2013CN103349758A Liver protecting Chinese medicine preparation for aquiculture animals and preparation method thereof
10/16/2013CN103349755A Fenticonazole nitrate and synthesis process thereof
10/16/2013CN103349717A Compound medicine for treating difficult-to-heal wounds, multiple wounds and suppurative diseases
10/16/2013CN103349713A Natural pharmaceutical extractive, as well as preparation method and use thereof
10/16/2013CN103349711A Anti-aging combination with resveratrol and preparation method thereof
10/16/2013CN103349710A Compound tilmicosin clathrate complex and preparation method thereof
10/16/2013CN103349703A Natural pharmaceutical composition, as well as preparation method and use thereof
10/16/2013CN103349702A Natural medicine composition and preparation method and purposes thereof
10/16/2013CN103349698A Natural pharmaceutical extractive, and preparation method thereof
10/16/2013CN103349697A Natural medicine extractive and preparation method and uses thereof
10/16/2013CN103349693A Preparation and using method of pure Chinese herbal medicine composition for treating allergic rhinitis
10/16/2013CN103349689A Drug for treating ulcers and sores
10/16/2013CN103349688A Bone disease treatment medicine
10/16/2013CN103349681A Natural medicine composition
10/16/2013CN103349680A Natural pharmaceutical extractive
10/16/2013CN103349676A Compound tilmicosin soluble powder, preparation method and application thereof
10/16/2013CN103349674A Tortoise shell rana japonica oil composition for increasing bone density and preventing osteoporosis
10/16/2013CN103349673A Plumbum-expelling agent
10/16/2013CN103349671A Resveratrol and spirulina composition and preparations and preparation method thereof
10/16/2013CN103349669A Malic acid-containing composite dialysis preparation and preparation method thereof
10/16/2013CN103349668A Application of Polyflavanostilbene A in preparing drug for treating endometrial cancer
10/16/2013CN103349667A Use of icariin in prevention and treatment of traumatic brain injury
10/16/2013CN103349666A Pharmaceutical composition injection of compound liposoluble vitamin and preparation method thereof
10/16/2013CN103349665A High calcium syrup
10/16/2013CN103349664A Steroidal c- 17 benzoazoles
10/16/2013CN103349663A Compound clobetasol propionate lipid composite ointment and preparation method thereof
10/16/2013CN103349662A Application of Myriberine A in anti-depression drug preparation
10/16/2013CN103349661A Preparation method and application of formononetin-5-FU mixture
10/16/2013CN103349660A New application of 8-methoxy-dihydrochelerythrine in preparation of STAT3 (signal transducer and activator of transcription3) signal path inhibitor
10/16/2013CN103349659A Liquid compositions and application
10/16/2013CN103349657A Risperidone film-shaped preparation
10/16/2013CN103349656A Valsartan capsule and preparation method thereof
10/16/2013CN103349655A Tamoxifen citrate enteric capsules
10/16/2013CN103349654A Cefuroxime axetil pharmaceutical composition
10/16/2013CN103349653A Lafutidine composition and preparation method thereof
10/16/2013CN103349652A High drug load tablet containing tetrahydronaphthalene amide compound or pharmaceutically acceptable salt thereof
10/16/2013CN103349651A Nifedipine sustained release tablet and preparation method thereof
10/16/2013CN103349650A Tamoxifen citrate sustained-release tablets
10/16/2013CN103349649A Tamoxifen citrate dispersible tablets
1 ... 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 ... 7860